News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,733 Results
Type
Article (45152)
Company Profile (275)
Press Release (693289)
Multimedia
Podcasts (221)
Webinars (20)
Section
Business (205691)
Career Advice (2074)
Deals (35709)
Drug Delivery (146)
Drug Development (82076)
Employer Resources (174)
FDA (16681)
Job Trends (15076)
News (348734)
Policy (33125)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2644)
Accelerated approval (48)
Adcomms (26)
Allergies (171)
Alliances (49796)
ALS (212)
Alzheimer's disease (1805)
Antibody-drug conjugate (ADC) (450)
Approvals (17045)
Artificial intelligence (682)
Autoimmune disease (290)
Automation (57)
Bankruptcy (366)
Best Places to Work (11694)
BIOSECURE Act (22)
Biosimilars (222)
Biotechnology (178)
Bladder cancer (188)
Brain cancer (73)
Breast cancer (748)
Cancer (5814)
Cardiovascular disease (499)
Career advice (1762)
Career pathing (44)
CAR-T (334)
CDC (61)
Celiac Disease (3)
Cell therapy (917)
Cervical cancer (47)
Clinical research (71180)
Collaboration (2073)
Company closure (5)
Compensation (1390)
Complete response letters (82)
COVID-19 (2757)
CRISPR (108)
C-suite (1120)
Cystic fibrosis (154)
Data (7869)
Decentralized trials (3)
Denatured (81)
Depression (162)
Dermatology (87)
Diabetes (591)
Diagnostics (6944)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (325)
Drug pricing (209)
Drug shortages (33)
Duchenne muscular dystrophy (289)
Earnings (92252)
Editorial (66)
Employer branding (21)
Employer resources (154)
Events (119896)
Executive appointments (1084)
FDA (20417)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1732)
Gene editing (239)
Generative AI (59)
Gene therapy (741)
GLP-1 (1088)
Government (4800)
Grass and pollen (6)
Guidances (410)
Healthcare (19147)
HIV (79)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (97)
Immunology and inflammation (296)
Immuno-oncology (92)
Indications (191)
Infectious disease (3095)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (136)
Intellectual property (290)
Interviews (326)
IPO (16708)
IRA (54)
Job creations (3684)
Job search strategy (1457)
JPM (63)
Kidney cancer (19)
Labor market (101)
Layoffs (572)
Leadership (41)
Legal (8061)
Liver cancer (99)
Longevity (33)
Lung cancer (763)
Lymphoma (430)
Machine learning (61)
Management (60)
Manufacturing (1058)
MASH (190)
Medical device (14058)
Medtech (14180)
Mergers & acquisitions (20244)
Metabolic disorders (1540)
mRNA (213)
Multiple sclerosis (187)
NASH (18)
Neurodegenerative disease (420)
Neuropsychiatric disorders (108)
Neuroscience (3321)
Neurotech (1)
NextGen: Class of 2026 (6616)
Non-profit (4578)
Now hiring (78)
Obesity (728)
Opinion (296)
Ovarian cancer (219)
Pain (252)
Pancreatic cancer (299)
Parkinson's disease (362)
Partnered (34)
Patents (595)
Patient recruitment (672)
Peanut (62)
People (59809)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22148)
Phase 2 (31309)
Phase 3 (23303)
Pipeline (8706)
Policy (339)
Postmarket research (2686)
Preclinical (9502)
Press Release (64)
Prostate cancer (299)
Psychedelics (60)
Radiopharmaceuticals (322)
Rare diseases (1090)
Real estate (6022)
Recruiting (71)
Regulatory (25658)
Reports (56)
Research institute (2454)
Resumes & cover letters (357)
Rett syndrome (39)
RNA editing (25)
RSV (88)
Schizophrenia (177)
Series A (292)
Series B (215)
Service/supplier (11)
Sickle cell disease (113)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (49)
Startups (3682)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (90)
The Weekly (137)
Vaccines (1112)
Venture capital (114)
Weight loss (482)
Women's health (130)
Worklife (21)
Date
Last 7 days (860)
Last 30 days (3333)
Last 365 days (30147)
2026 (12471)
2025 (30330)
2024 (35373)
2023 (40205)
2022 (51305)
2021 (55838)
2020 (54291)
2019 (46818)
2018 (35271)
2017 (32374)
2016 (31814)
2015 (37910)
2014 (31696)
2013 (26816)
2012 (29066)
2011 (29815)
2010 (28184)
Location
Africa (760)
Alabama (93)
Alaska (7)
Arizona (351)
Arkansas (14)
Asia (40138)
Australia (6659)
California (13272)
Canada (3772)
China (1350)
Colorado (566)
Connecticut (580)
Delaware (404)
Europe (87334)
Florida (1984)
Georgia (427)
Hawaii (3)
Idaho (62)
Illinois (1055)
India (90)
Indiana (599)
Iowa (23)
Japan (537)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1593)
Massachusetts (9453)
Michigan (364)
Minnesota (718)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3481)
New Mexico (29)
New York (3468)
North Carolina (1689)
North Dakota (9)
Northern California (6650)
Ohio (399)
Oklahoma (23)
Oregon (42)
Pennsylvania (2672)
Puerto Rico (29)
Rhode Island (50)
South America (1135)
South Carolina (85)
South Dakota (2)
Southern California (5233)
Tennessee (210)
Texas (2108)
United States (46799)
Utah (393)
Vermont (1)
Virginia (323)
Washington D.C. (80)
Washington State (1063)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
738,733 Results for "jarvik heart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
April 29, 2026
·
6 min read
Press Releases
WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure
May 10, 2026
·
6 min read
Artificial intelligence
Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma
In recent months, Anthropic has been building more and more ties with the biopharma industry, including partnerships with Big Pharma companies such as Sanofi, Novo Nordisk and AbbVie.
April 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 12, 2026
·
10 min read
Press Releases
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
April 22, 2026
·
8 min read
Press Releases
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
April 26, 2026
·
7 min read
Press Releases
Reprieve Cardiovascular Announces Publication of FASTR Pilot Trial Results in JACC: Heart Failure
May 8, 2026
·
5 min read
Press Releases
Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
May 7, 2026
·
7 min read
Press Releases
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
May 11, 2026
·
16 min read
Press Releases
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world’s largest pharmaceutical market. This allowance fortifies Cardiol’s global intellectual property portfolio, adding to granted and pending patent applications in Europe, Japan, Canada, Australia, and China.
November 13, 2025
·
6 min read
1 of 73,874
Next
